Evolving outcomes of extracorporeal membrane oxygenation support for severe COVID-19 ARDS in Sorbonne hospitals, Paris.
Matthieu SchmidtElise LangouetDavid HajageSarah Aissi JamesJuliette ChommelouxNicolas BréchotPetra BarhoumLucie LefèvreAntoine TrogerMarc Pineton de ChambrunGuillaume HékimianCharles-Edouard LuytMartin DresJean-Michel ConstantinMuriel FartoukhPascal LeprinceGuillaume LebretonAlain Combesnull nullPublished in: Critical care (London, England) (2021)
90-day mortality of ECMO-supported COVID-19-ARDS patients increased significantly after July 1, 2020, and was no longer comparable to that of non-COVID ECMO-treated patients. Failure of prolonged non-invasive oxygenation strategies before intubation and increased lung damage may partly explain this outcome.
Keyphrases
- extracorporeal membrane oxygenation
- acute respiratory distress syndrome
- coronavirus disease
- sars cov
- end stage renal disease
- newly diagnosed
- ejection fraction
- healthcare
- prognostic factors
- respiratory failure
- peritoneal dialysis
- mechanical ventilation
- type diabetes
- cardiac arrest
- metabolic syndrome
- oxidative stress
- insulin resistance
- coronary artery disease
- weight loss